TOP > 外国特許検索 > METHOD FOR PREPARING BONE MARROW CELL AGGREGATE

METHOD FOR PREPARING BONE MARROW CELL AGGREGATE

外国特許コード F160008849
整理番号 (S2015-0410-N0)
掲載日 2016年9月23日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP051009
国際公開番号 WO 2016121512
国際出願日 平成28年1月14日(2016.1.14)
国際公開日 平成28年8月4日(2016.8.4)
優先権データ
  • 特願2015-014194 (2015.1.28) JP
発明の名称 (英語) METHOD FOR PREPARING BONE MARROW CELL AGGREGATE
発明の概要(英語) Provided is a technique whereby bone marrow cells can be organized by a simple method within a short period of time. A method for preparing a bone marrow cell aggregate, said method comprising adding a bone marrow cell mass-containing liquid to a medium that contains a swellable material, and culturing the bone marrow cell mass in the presence of the swellable material. A method for reconstructing a bone marrow tissue, said method comprising adding a bone marrow cell mass-containing liquid to a medium that contains a swellable material, and culturing the bone marrow cell mass in the presence of the swellable material. As the common sense in the art, it has been believed that, after disintegrating a bone marrow tissue, cell masses can be hardly reorganized while keeping the cell composition unchanged, i.e., without adding "a binder" such as adhesive cells or intracellular matrix. In fact, such cell masses cannot be aggregated by methods generally employed in the art. The present invention provides a remarkable breakthrough technique relating to the three-dimensional culture of bone marrow cells to thereby overcome the above problem and situation encountered in the prior art. It is also confirmed that a bone marrow-like tissue reconstructed by the method according to the present invention can be continuously cultured in a methyl celluose-containing medium until the 14th day.
従来技術、競合技術の概要(英語) BACKGROUND ART
Such as a mouse or human bone marrow tissue is, play an important role as a hematopoietic tissue. Hematopoietic and clarification of the mechanism for disease related thereto, the bone marrow tissue reconstruction technique plays an important role. However, for most blood cells in bone marrow Mn, fall apart once again and it is difficult to organize.
As the bone marrow for culture techniques, known Dexter culture (non-patent document 1: Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977 Jun; 91 (3): 335-44.). This is because the stromal cells as a feeder, on which the maintenance of hematopoietic stem cells, to differentiate into a variety of cell culture method allows. Planar culture is performed in that environment.
The culture of 3 using a technique of performing a three-dimensional scaffold present (non-patent document 2: Nichols JE, Cortiella J, Lee J, Niles JA, Cuddihy M, Wang S, Bielitzki J, Cantu A, Mlcak R, Valdivia E, Yancy R, McClure ML, Kotov NA. In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials. 2009 Feb; 30 (6): 1071-9, non-patent document 3: Leisten I, Kramann R, Ventura Ferreira MS, Bovi M, Neuss S, Ziegler P, Wagner W, Knuchel R, Schneider RK. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials. 2012 Feb; 33 (6): 1736-47.).
Sawa Harvard University Wyss Institute birds 3 - dimensional reconstruction of the bone marrow via the courage et al. for utilizing the microfluidic device by the method reported study (non-patent document 4: Yu-suke Torisawa, Catherine S Spina, Tadanori Mammoto, Akiko Mammoto, James C Weaver, Tracy Tat, James J Collins, Donald E Ingber, Nature Methods, Vol11, JUNE, 663-669 2014) Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro,. They can be confirmed with the various hematopoietic phenomenon and in vitro. The actual reconstruction procedures include, cylindrical poly(dimethylsiloxane) (PDMS) in the hollow portion of bone to reconstruct the packed material, such as a mouse can be implanted into the body, to reconstruct the bone and bone marrow. Is embedded at the device body, not at all using live cells, bone marrow cells may be blood to move toward the via. The duration of implantation is required for 8 weeks. 8 Weeks after the bone marrow in the body tissue and the tissue was removed, the microfluidic device is used in in vitro perfusion hematopoietic phenomenon can be examined.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY
  • 発明者(英語)
  • KOJIMA NOBUHIKO
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
※ ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close